(Louis et al., 2014; Louis et al., 2016) In the 2021 revised version, novel molecular indicators, including telomerase reverse transcriptase (TERT) promoter alterations and epidermal growth factor receptor (EGFR) gene amplification, are required to classify adult patients with gliomas. Here, EGFR is linked to glioma.